C1435644||Renieramycin M
C1956422||Cancer Stem Cell
C0597032||H460
C0024109||Lung
C0597032||Cancer Cells
C1956422||Cancer stem cells
C1956422||Cancer stem cells
C0597032||cancer cells
C1155711||self-renewal
C0007589||differentiation
C1956422||Cancer stem cells
C0013203||drug-resistance
C4255448||metastasis
C1956422||CSC
C0087111||therapeutic strategies
C1516225||cancer research
C2603343||study
C1435644||renieramycin M
C1435644||renieramycin M
C0032699||sponge
C1204055||Xestospongia species
C0332128||examined
C0024109||lung
C1956422||Cancer stem cells
C0005507||Colony and spheroid formation assays
C0005863||western blotting analysis
C0024109||lung
C1956422||CSC
C0033684||protein
C0041365||markers
C1956422||CSC
C0597032||H460
C0024109||lung
C0597032||cancer cells
C0087111||treatment
C1435644||renieramycin M
C1435644||renieramycin M
C0087111||treatment
C0005507||colony and spheroid formation
C0597032||H460 cells
C1956422||CSC
C0041365||markers
C0673026||CD133
C1097299||CD44
C1721673||ALDH1A1
C1956422||CSC
C0597032||H460 cells
C1435644||renieramycin M
C0087111||treatment
C1435644||renieramycin M
C1516021||anti-metastatic agent
C0024109||lung
C1956422||CSC
C0597032||H460 cells